Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Optic and auditory pathway dysfunction in demyelinating neuropathies.
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.
A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
A rare association of tuberculous longitudinally extensive transverse myelitis (LETM) with brain tuberculoma.
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
[Symptoms and clinical manifestations in neuromyelitis optica].
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis.
Glucocorticoid treatment of multiple sclerosis.
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
The use of valproic acid and multiple sclerosis.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.

Pages